Design Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Design Therapeutics (Nasdaq: DSGN) will present at two investor conferences in early 2026: Oppenheimer 36th Annual Healthcare Life Sciences on Feb 25, 2026 at 1:20 PM ET (virtual) and Leerink Partners Global Healthcare on Mar 10, 2026 at 2:20 PM ET in Miami.

Live webcasts will be available on the company’s investor website and archived for at least 30 days after each presentation.

CARLSBAD, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will present at the following upcoming investor conferences:

• Oppenheimer 36^th Annual Healthcare Life Sciences Conference on Wednesday, February 25, 2026, at 1:20 p.m. ET (virtual)
• Leerink Partners Global Healthcare Conference on Tuesday, March 10, 2026, at 2:20 p.m. ET in Miami, FL

Live webcasts of each presentation will be available here and in the investors section of the company’s website at www.designtx.com.The webcasts will be archived for at least 30 days following each presentation.

About Design Therapeutics
Design Therapeutics is a clinical-stage biotechnology company developing a new class of therapies based on its platform of GeneTAC^® gene targeted chimera small molecules. The company’s GeneTAC^® molecules are designed to either dial up or dial down the expression of a specific disease-causing gene to address the underlying cause of disease. In addition to its clinical-stage GeneTAC^® programs, DT-216P2, in development for patients with Friedreich ataxia, and DT-168, for Fuchs endothelial corneal dystrophy, the company is advancing DT-818 for myotonic dystrophy type-1, and a program in Huntington’s disease. Discovery efforts are underway for multiple genomic medicines. For more information, please visit designtx.com.

Contact:
Renee Leck, THRUST
renee@thrustsc.com

FAQ

When will Design Therapeutics (DSGN) present at the Oppenheimer Healthcare Life Sciences Conference?

Design Therapeutics will present on Wednesday, Feb 25, 2026 at 1:20 PM ET. According to the company, the presentation is virtual and a live webcast will be available on the investor website and archived for at least 30 days.

What are the details for Design Therapeutics (DSGN) presentation at the Leerink Partners Global Healthcare Conference?

Design Therapeutics will present on Tuesday, Mar 10, 2026 at 2:20 PM ET in Miami. According to the company, the session will be live and the webcast will be posted on the company investor site and archived for at least 30 days.

Where can investors watch the DSGN conference webcasts and how long will they be available?

Investors can watch live webcasts via the company investor website and the designated conference webcast links. According to the company, each webcast will be archived and available for at least 30 days after the presentation.

Will Design Therapeutics (DSGN) presentations be available to non-attendees after the conferences?

Yes, presentations will be accessible after the events via webcast archives. According to the company, each presentation’s webcast will be archived on the investor site for a minimum of 30 days following the event.

How can shareholders find the DSGN investor webcast schedule and access links for Feb–Mar 2026?

Shareholders can find schedule and access links on the company investor relations website. According to the company, live webcasts for Feb 25 and Mar 10 will be posted there and archived for at least 30 days.